Get the Stockscreener App
9.70
14.99%
-1.71
Quantum Biopharma Ltd stock is traded at $9.70, with a volume of 660.51K.
It is down -14.99% in the last 24 hours and down -25.15% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$11.41
Open:
$12
24h Volume:
660.51K
Relative Volume:
3.23
Market Cap:
$37.02M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+68.40%
1M Performance:
-25.15%
6M Performance:
+65.25%
1Y Performance:
+326.37%
1-Day Range:
$9.45
$12.42
1-Week Range:
$6.03
$12.42
52-Week Range:
$1.35
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
9.70 | 43.55M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Cannabis Stocks To ResearchNovember 28th - MarketBeat
REPEAT: Award-winning Investigative News Program W5 Airs - GlobeNewswire
Quantum Biopharma's $700 Mln Market Manipulation Case Featured In CTV W5 Investigative Series - Nasdaq
Quantum BioPharma Alleges Stock Manipulation in $700M Lawsuit - TipRanks
Award-winning Investigative News Program W5 Airs Part 2 of - GlobeNewswire
How Quantum BioPharma Ltd. stock reacts to global recession fearsJuly 2025 Levels & Real-Time Market Sentiment Alerts - moha.gov.vn
Top Cannabis Stocks To ConsiderNovember 27th - MarketBeat
BioVaxys Announces Extension of Life Offering Closing Date - Investing News Network
Will Quantum BioPharma Ltd. stock attract ESG investorsProfit Target & Safe Capital Allocation Plans - moha.gov.vn
‘Market manipulation’ cases trending up in Canada: regulator data - CTV News
Quantum BioPharma Shares Surge 32% After Lawsuit Investigation News Coverage - Nasdaq
Quantum BioPharma Featured in CTV Investigation on Stock Manipulation Allegations - citybuzz
Quantum BioPharma’s Stock Manipulation Allegations Spotlighted by CTV’s W5 - TipRanks
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock - GlobeNewswire
Quantum BioPharma’s $700M Lawsuit Featured in CTV’s W5 Series - TipRanks
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 - GlobeNewswire Inc.
Is Quantum BioPharma Ltd. a good long term investmentVolatility Index Analysis & These Stocks Are Just Getting Started - earlytimes.in
Why Quantum BioPharma Ltd. (0K91) stock stays undervaluedDividend Hike & Momentum Based Trading Ideas - newser.com
Can Quantum BioPharma Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Can Quantum BioPharma Ltd. (0K91) stock stage a strong rebound this quarter2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
Will Quantum BioPharma Ltd. stock benefit from commodity pricesPortfolio Value Report & Low Drawdown Momentum Ideas - newser.com
Is Quantum BioPharma Ltd. (0K91) stock expanding market penetrationMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com
How to monitor Quantum BioPharma Ltd. with trend dashboardsWeekly Trend Summary & Daily Price Action Insights - newser.com
Real time scanner hits for Quantum BioPharma Ltd. explainedQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
Custom watchlist performance reports with Quantum BioPharma Ltd.2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
Why Quantum BioPharma Ltd. stock attracts high net worth investorsIPO Watch & Entry Point Strategy Guides - newser.com
Can Quantum BioPharma Ltd. stock beat analyst upgrades2025 Institutional Moves & Daily Stock Momentum Reports - newser.com
Will Quantum BioPharma Ltd. stock go up soonQuarterly Trade Review & Long-Term Growth Portfolio Plans - newser.com
Order flow analysis tools used on Quantum BioPharma Ltd.Earnings Risk Report & Daily Growth Stock Tips - newser.com
How Quantum BioPharma Ltd. (0K91) stock correlates with oil marketsPortfolio Return Summary & Expert-Curated Trade Recommendations - newser.com
Predicting Quantum BioPharma Ltd. trend using moving averages2025 Market Outlook & Growth Focused Investment Plans - newser.com
Full technical analysis of Quantum BioPharma Ltd. stock2025 Historical Comparison & Verified Short-Term Plans - newser.com
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):